First Tracks Analyst Price Targets

Wall Street analyst price targets and consensus rating for First Tracks (TRAX).

Price Target Range — 2 Quarters

Analyst Consensus — 11 Analysts

11Buy

Consensus RatingOverweight# Analysts11Avg. Consensus PT$64Upside to Avg. PT+91.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 30, 2026	Canaccord Genuity	Edward Nash	Initiate	Buy	$50
Sep 18, 2026	Evercore ISI Group	Gavin Clark-Gartner	Initiate	Outperform	$65
Sep 16, 2026	Guggenheim	Yatin Suneja	Initiate	Buy	$100
Sep 3, 2026	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$57
Aug 13, 2026	Piper Sandler	Yasmeen Rahimi	PT Raise	Overweight	$54→$95
Aug 13, 2026	Barclays	Etzer Darout	PT Raise	Overweight	$48→$65
Aug 13, 2026	Wedbush	Martin Fan	PT Raise	Outperform	$60→$70
Aug 13, 2026	HC Wainwright & Co.	Emily Bodnar	PT Raise	Buy	$44→$57
Aug 10, 2026	UBS	Michael Yee	PT Raise	Buy	$45→$65
Jul 28, 2026	Wedbush	Martin Fan	PT Raise	Outperform	$30→$60
Jul 28, 2026	Wells Fargo	Derek Archila	PT Raise	Overweight	$30→$55
Jul 21, 2026	Barclays	Etzer Darout	PT Raise	Overweight	$40→$48
Jul 10, 2026	HC Wainwright & Co.	Emily Bodnar	PT Raise	Buy	$30→$44
Jul 8, 2026	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$30
Jun 8, 2026	Wells Fargo	Derek Archila	Initiate	Overweight	$30
May 4, 2026	Piper Sandler	Yasmeen Rahimi	Initiate	Overweight	$54
Apr 28, 2026	HC Wainwright & Co.	Emily Bodnar	Initiate	Buy	$30
Apr 24, 2026	Leerink Partners	David Risinger	Initiate	Outperform	$46
Apr 23, 2026	JP Morgan	Anupam Rama	Initiate	Overweight	$31
Apr 22, 2026	Barclays	Etzer Darout	Initiate	Overweight	$40

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Canaccord Genuity Initiates Coverage On First Tracks with Buy Rating, Announces Price Target of $50

Canaccord Genuity analyst Edward Nash initiates coverage on First Tracks (NASDAQ:TRAX) with a Buy rating and announces Price Target of $50.

Benzinga Newsdesk

This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Analysts initiated bullish coverage on TRAX, BGSI, NPCE, CUE and NGVC, assigning Outperform/Buy ratings with price targets from $18 to $120.

Avi Kapoor

PRO
Evercore ISI Group Initiates Coverage On First Tracks with Outperform Rating, Announces Price Target of $65

Evercore ISI Group initiates coverage on First Tracks (NASDAQ:TRAX) with a Outperform rating and announces Price Target of $65.

Benzinga Newsdesk

PRO
Guggenheim Initiates Coverage On First Tracks with Buy Rating, Announces Price Target of $100

Guggenheim analyst Yatin Suneja initiates coverage on First Tracks (NASDAQ:TRAX) with a Buy rating and announces Price Target of $100.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on First Tracks, Maintains $57 Price Target

HC Wainwright & Co. analyst Emily Bodnar reiterates First Tracks (NASDAQ:TRAX) with a Buy and maintains $57 price target.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on First Tracks, Raises Price Target to $65

Barclays analyst Etzer Darout maintains First Tracks (NASDAQ:TRAX) with a Overweight and raises the price target from $48 to $65.

Benzinga Newsdesk

First Tracks Biotherapeutics Inc

First Tracks Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Canaccord Genuity Initiates Coverage On First Tracks with Buy Rating, Announces Price Target of $50

This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

PRO
Evercore ISI Group Initiates Coverage On First Tracks with Outperform Rating, Announces Price Target of $65

PRO
Guggenheim Initiates Coverage On First Tracks with Buy Rating, Announces Price Target of $100

PRO
HC Wainwright & Co. Reiterates Buy on First Tracks, Maintains $57 Price Target

PRO
Barclays Maintains Overweight on First Tracks, Raises Price Target to $65

People Also Watch

People Also Watch

First Tracks Biotherapeutics Inc

First Tracks Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROCanaccord Genuity Initiates Coverage On First Tracks with Buy Rating, Announces Price Target of $50

This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

PROEvercore ISI Group Initiates Coverage On First Tracks with Outperform Rating, Announces Price Target of $65

PROGuggenheim Initiates Coverage On First Tracks with Buy Rating, Announces Price Target of $100

PROHC Wainwright & Co. Reiterates Buy on First Tracks, Maintains $57 Price Target

PROBarclays Maintains Overweight on First Tracks, Raises Price Target to $65

People Also Watch

People Also Watch

PRO
Canaccord Genuity Initiates Coverage On First Tracks with Buy Rating, Announces Price Target of $50

PRO
Evercore ISI Group Initiates Coverage On First Tracks with Outperform Rating, Announces Price Target of $65

PRO
Guggenheim Initiates Coverage On First Tracks with Buy Rating, Announces Price Target of $100

PRO
HC Wainwright & Co. Reiterates Buy on First Tracks, Maintains $57 Price Target

PRO
Barclays Maintains Overweight on First Tracks, Raises Price Target to $65